Nephrocalcinosis at Baseline Did Not Increase the Risk of Nephrocalci-nosis Progression After Long-Term Burosumab Treatment in Adults and Children with X-Linked Hypophosphatemia (XLH).
2020
https://researcherprofiles.org/profile/513920688
Farzana Perwad, Angel Chen, Lin Zhang, Mary Scott Roberts, Anthony A. Portale
